Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02632045
Title Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer (MAINTAIN)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kevin Kalinsky
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.